High-dosage Δ1-testololactone therapy of disseminated carcinoma of the breast
- 1 January 1967
- Vol. 20 (3) , 458-461
- https://doi.org/10.1002/1097-0142(1967)20:3<458::aid-cncr2820200314>3.0.co;2-u
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Calcium and Phosphate Metabolism in Patients with Disseminated Breast Cancer: Effect of Androgens and of PrednisoneJournal of Clinical Endocrinology & Metabolism, 1963
- Metabolic and Serum Lipid Effects of 1-Testololactone.Experimental Biology and Medicine, 1962
- Hormonal therapy in cancer of the breast.XIX. Effect of oral administration of Δ1-testololactone on clinical course and hormonal excretionCancer, 1962
- Δ1-testololactone, a nonandrogenic augmentor and inhibitor of androgensCancer, 1960
- Hormonal therapy in cancer of the breast.XVI. The effect of Δ1-testololactone on clinical course and hormonal excretionCancer, 1960
- A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic TransaminasesAmerican Journal of Clinical Pathology, 1957
- TESTS FOR HYPERPARATHYROIDISM: TUBULAR REABSORPTION OF PHOSPHATE, PHOSPHATE DEPRIVATION, AND CALCIUM INFUSION*†Journal of Clinical Endocrinology & Metabolism, 1956
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955
- THE ESTIMATION OF SERUM INORGANIC PHOSPHATE AND "ACID" AND "ALKALINE" PHOSPHATASE ACTIVITYPublished by Elsevier ,1942
- THE DETERMINATION OF BILIRUBIN WITH THE PHOTOELECTRIC COLORIMETERJournal of Biological Chemistry, 1937